Concepedia

Liang Liang

LL

Statistics

Publications

56

Citations

3K

H-Index

28

Active since

1999

Affiliations

University of Rochester Medical Center(Current)

China Medical University Hospital

China Medical University

Guangxi Medical University

Xi'an Jiaotong University

Liang Liang is an author at University of Rochester Medical Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1999–2024

56

Publications

56

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer

Jie Wang, Shun Lü, Xinmin Yu et al. · JAMA Oncology · 2021 · 381 citations · Full text

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Shun Lü, Jie Wang, Yan Yu et al. · Journal of Thoracic Oncology · 2021 · 264 citations · Full text

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)

Yunpeng Yang, Jianji Pan, Hui Wang et al. · Cancer Cell · 2023 · 191 citations · Full text

, , +16

Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4–STAT3 Signaling

Lei-Ya Fang, Kouji Izumi, Kuo-Pao Lai et al. · Cancer Research · 2013 · 152 citations · Full text

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

Jayesh Desai, Sanjeev Deva, Jong Seok Lee et al. · Journal for ImmunoTherapy of Cancer · 2020 · 145 citations · Full text

1–5 of 56